If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

Q4 2025 Earnings Call Transcript June 17, 2025 Beyond Air, Inc. beats earnings expectations. Reported EPS is $-0.09, ...